Scribe Therapeutics Announces Research Collaboration with Sanofi to Accelerate Breakthrough CRISPR-based Cell Therapies for Cancer

ALAMEDA, Calif.–(BUSINESS WIRE)– #CRISPR–Sanofi selects Scribe’s CRISPR by Design™ platform to enable oncology pipeline of engineered natural killer (NK) cell therapies